Literature DB >> 8074727

Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha.

S Sugo1, N Minamino, H Shoji, K Kangawa, K Kitamura, T Eto, H Matsuo.   

Abstract

In this study, we demonstrate production and secretion of adrenomedullin (AM) from cultured vascular smooth muscle cells (VSMCs). In addition to endothelial cells (ECs), we found immunoreactive (ir-) AM in culture media of rat and bovine VSMCs in the survey for AM-producing cells. Although the secretion level of ir-AM was at most 1/6 that of rat ECs, all the examined VSMCs were shown to produce AM. By gel filtration, reverse phase high-performance liquid chromatography, and biological characterization, ir-AM in the culture medium was identified to be rat AM of 50 residues. By RNA blot analysis, a positive band of AM mRNA was detected in cultured VSMC at an intensity 3-4 fold higher than that in adrenal gland. Gene expression and production of AM were markedly augmented by tumor necrosis factor-alpha. Based on these data as well as the presence of AM specific receptors on VSMCs, AM secreted from VSMC is deduced to function as an autocrine or paracrine regulator in vascular cell communication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8074727     DOI: 10.1006/bbrc.1994.2241

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.

Authors:  P Hasbak; A Sams; S Schifter; J Longmore; L Edvinsson
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  Increased alphaCGRP potency and CGRP-receptor antagonist affinity in isolated hypoxic porcine intramyocardial arteries.

Authors:  Philip Hasbak; Karen Eskesen; Søren Schifter; Lars Edvinsson
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

3.  Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.

Authors:  Mathilde Fraty; Gilberto Velho; Elise Gand; Fréderic Fumeron; Stéphanie Ragot; Philippe Sosner; Kamel Mohammedi; Barnabas Gellen; Pierre-Jean Saulnier; Jean-Michel Halimi; David Montaigne; Grégory Ducrocq; Michaela Rehman; Michel Marre; Ronan Roussel; Samy Hadjadj
Journal:  Diabetologia       Date:  2018-09-19       Impact factor: 10.122

4.  Adrenomedullin and nitric oxide in children with detrusor instability.

Authors:  Ayşe Balat; Kemal Sarica; Mustafa Cekmen; Muhittin Yürekli; Faruk Yağci; Ahmet Erbağci
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

Review 5.  Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.

Authors:  Kazuhiro Takahashi; Ryo Morimoto; Takuo Hirose; Fumitoshi Satoh; Kazuhito Totsune
Journal:  J Mol Neurosci       Date:  2010-07-02       Impact factor: 3.444

Review 6.  Novel neurohumoral factors in congestive heart failure: adrenomedullin.

Authors:  J G Lainchbury
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

Review 7.  SPECT and PET imaging of adrenomedullin receptors: a promising strategy for studying pulmonary vascular diseases.

Authors:  Luis Michel Alonso Martinez; François Harel; Myriam Létourneau; Vincent Finnerty; Alain Fournier; Jocelyn Dupuis; Jean N DaSilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2019-10-15

Review 8.  Adrenomedullin and diabetes.

Authors:  Hoi Kin Wong; Fai Tang; Tsang Tommy Cheung; Bernard Man Yung Cheung
Journal:  World J Diabetes       Date:  2014-06-15

Review 9.  Adrenomedullin in vascular diseases.

Authors:  Katsuyuki Ando; Tatsuo Shimosawa; Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

10.  Plasma adrenomedullin level in Egyptian children and adolescents with type 1 diabetes mellitus: relationship to microvascular complications.

Authors:  Safinaz A El-Habashy; Randa M Matter; Eman S El-Hadidi; Hala R Afifi
Journal:  Diabetol Metab Syndr       Date:  2010-02-10       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.